Enact Holdings, Inc. (ACT) Stock News

A class action lawsuit has been filed against Planet Fitness for allegedly making false statements about its Black Card price increase rollout, membership growth projections, and marketing effectiveness. The company cut its 2026 revenue growth guidance from 9% to 7% and paused its planned Black Card price increase, causing the stock to plunge 31% on May 7, 2026.

A class action lawsuit has been filed against PicS N.V. (PicPay) alleging that IPO offering documents contained false and misleading statements regarding credit evaluation procedures, loan quality, and undisclosed credit deterioration. The stock has declined over 50% from its $19 IPO price to below $9 per share. Investors have until August 4, 2026 to apply for lead plaintiff status.

A class action lawsuit has been filed against Hub Group, Inc. for allegedly making false and misleading statements regarding its financial statements from Q1 2023 through Q3 2025. The company allegedly made material misstatements concerning revenue recognition, operating income, and expense reporting due to premature transaction recognition and cost understatement. Investors who purchased shares between April 28, 2023, and May 11, 2026, may be eligible to participate in the lawsuit.

DSV A/S reported EBIT before special items of DKK 6,255 million for Q2 2026, demonstrating positive earnings growth despite volatile market conditions. The company will release its full H1 2026 interim results on July 22, 2026, with a webcast and conference call at 11:00 am CEST.

A class action lawsuit has been filed against ADMA Biologics for allegedly making false statements about its business operations. The lawsuit claims the company engaged in undisclosed related party transactions, used channel stuffing to inflate revenues, and lacked adequate internal controls. Following a short report by Culper Research on March 24, 2026, ADMA's stock fell 16.63%. Investors who purchased shares between August 9, 2024 and March 25, 2026 can join the lawsuit with a deadline of August 10, 2026.

Telix Pharmaceuticals announced publication of ProstACT SELECT Phase 1 study results in peer-reviewed journal Cancers, demonstrating that 68Ga-PSMA-PET imaging can reliably identify patients suitable for TLX591-Tx therapy. The study showed TLX591-Tx achieved a median radiographic progression-free survival of 8.8 months with a manageable safety profile in advanced metastatic prostate cancer patients, supporting the ongoing Phase 3 ProstACT Global trial.

Moore Law PLLC is investigating Grindr Inc.'s $500 million stock repurchase program, alleging the board breached fiduciary duties by allowing buybacks to continue despite knowing they would push Chairman G. Raymond Zage III's ownership above 50% without requiring a control premium. The repurchases reduced outstanding shares to 187,032,103 by September 2025, increasing Zage's beneficial ownership to approximately 50.11%. Grindr stock has declined approximately 25% over the past 12 months.

A class action lawsuit has been filed against Zoetis, Inc. for allegedly making materially false statements and failing to disclose material adverse facts during the period from January 14, 2025 to May 6, 2026. The complaint alleges that Zoetis concealed weakening veterinarian adoption of its Librela product due to FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors have until July 27, 2026 to apply to be appointed as lead plaintiff.

Soitec reports on its liquidity contract managed by BNP Paribas for the first half of 2026. During H1 2026, 227,346 shares were purchased for €17.36 million and 288,875 shares were sold for €23.29 million across 4,546 transactions. The liquidity account held 24,442 shares and €6.36 million as of June 30, 2026.

A class action lawsuit has been filed against PicS N.V. (PicPay) alleging that IPO offering documents contained false and misleading statements regarding credit evaluation procedures, loan quality, and undisclosed credit deterioration. The stock has declined over 50% from its $19 IPO price to below $9 per share. Investors have until August 4, 2026 to apply to be appointed as lead plaintiff.

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false and misleading statements regarding revenue and cost recording. The company allegedly overstated revenue, assets, and accounts receivable due to deficient internal controls, requiring financial statement restatement. Investors who purchased Veritone securities between October 14, 2025 and April 14, 2026 have until July 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Peabody Energy Corporation for allegedly providing false and misleading statements regarding its Centurion mine operations. The company failed to disclose material adverse facts about production delays and ramp-up issues. Following guidance cuts announced on March 30, 2026 and May 5, 2026, the stock declined significantly, with investors losing substantial value during the class period from October 14, 2024 to May 4, 2026.

A securities class action lawsuit has been filed against Insulet Corporation alleging the company made false and misleading statements about its manufacturing controls and procedures. The lawsuit covers investors who purchased Insulet securities between February 21, 2025 and May 26, 2026. Two voluntary medical device corrections were disclosed in March and May 2026 involving manufacturing issues with Omnipod products, resulting in significant stock price declines. The deadline to seek lead plaintiff status is August 31, 2026.

Moore Law PLLC is investigating ICON plc (NASDAQ: ICLC) following the company's announcement of an internal audit committee investigation into accounting practices and controls initiated in October 2025. ICON's stock price dropped significantly on February 12, 2026, when the company disclosed the investigation and delayed its earnings release to April 30, 2026.

Moore Law PLLC is investigating Super Micro Computer, Inc. (SMCI) for potential securities fraud following multiple disclosures in August-September 2024. The company revealed margin pressures on August 6, faced Hindenburg Research allegations of fraudulent revenue recognition and accounting irregularities on August 27, announced delayed 10-K filing on August 28, and faced a DOJ investigation announcement on September 26. These events triggered significant stock price declines totaling over 34% across the disclosure period.

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false and misleading statements regarding its financial records. The company is accused of inaccurately recording revenue and costs, overstating assets and accounts receivable, and maintaining deficient internal controls. Investors who purchased Veritone securities between October 14, 2025 and April 14, 2026 have until July 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Microsoft Corporation in the U.S. District Court for the Western District of Washington on behalf of investors who purchased Microsoft stock between May 1, 2025 and January 28, 2026. The lawsuit alleges that Microsoft made false or misleading statements regarding significant problems with its Copilot AI products, including brand positioning, user experience, and competitive positioning issues. The company allegedly failed to disclose that it needed to increase capital expenditures by billions of dollars and divert GPU/CPU capacity from Azure services to improve Copilot's competitiveness. Investors have until August 11, 2026 to apply to be appointed as lead plaintiff.

A federal securities class action has been filed against FS KKR Capital Corp. (FSK) alleging that the company and its executives made false and misleading statements regarding portfolio restructuring effectiveness, investment valuations, and dividend sustainability. The lawsuit covers investors who purchased FSK stock between May 8, 2024 and February 25, 2026. The deadline to seek lead plaintiff appointment is July 3, 2026.

ADMA Biologics faces a federal securities class action lawsuit alleging the company made false statements about its financial performance through channel stuffing schemes and undisclosed related party transactions. An investigative report revealed ADMA artificially inflated 2025 revenue growth from -3% to +20% by inducing distributors to overstock products with rebates and extended payment terms. The stock declined 29% following the report's publication on March 24, 2026. Investors who purchased securities between August 9, 2024 and March 25, 2026 may be eligible to participate, with a deadline of August 10, 2026 to seek lead plaintiff status.

A federal securities class action has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging that the company and its executives made false and misleading statements about the Fabric Genomics acquisition and overstated the durability of reimbursement rates. On May 4, 2026, GeneDx disclosed missed Q1 results, cut 2026 guidance from $540-555 million to $475-490 million, and took a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition purchased for $36.5 million one year prior. The stock fell over 49% on the news. Investors who purchased GeneDx stock between April 16, 2025 and May 4, 2026 may be eligible to participate in the lawsuit, with a deadline of August 3, 2026 to seek lead plaintiff appointment.

A securities class action lawsuit has been filed against Peabody Energy Corporation for allegedly making false and misleading statements about its Centurion mine operations. The company provided overly positive guidance while concealing material operational challenges. Stock price declined significantly following corrective disclosures on March 30, 2026 (9.7% drop) and May 5, 2026 (5.7% drop) when the company revealed commissioning delays and reduced production guidance. The deadline to seek lead plaintiff status is August 24, 2026.

A federal securities class action has been filed against AeroVironment, Inc. alleging that the company and its executives made false and misleading statements by concealing imminent competition for its SCAR program contracts and overstating business prospects. Investors who purchased AVAV stock between June 25, 2025 and March 10, 2026 may be eligible to participate. The deadline to seek lead plaintiff appointment is July 27, 2026.

A federal securities class action has been filed against Roblox Corporation alleging that executives made false and misleading statements about the company's organic growth potential. The lawsuit claims Roblox concealed that its age verification rollout would significantly slow growth rates and reduce engagement. On April 30, 2026, when Roblox revealed the true impact and slashed guidance, its stock plummeted 18.33% in a single day. Investors who purchased RBLX securities between October 30, 2025 and April 30, 2026 may be eligible to participate, with the lead plaintiff deadline set for August 7, 2026.

A securities class action lawsuit has been filed against Nano-X Imaging (NNOX) alleging the company made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased cash burn, and restructuring risks. The lawsuit covers purchases between March 31, 2025 and April 17, 2026. Investors have until August 11, 2026 to seek lead plaintiff status. The action follows Nano-X's April 2026 announcement of a $33.4 million quarterly loss including a $17.5 million asset impairment charge, which triggered a 24.39% stock price decline.

Faruqi & Faruqi, LLP is investigating a federal securities class action against Lucid Group for allegedly making false and misleading statements about supplier quality issues that disrupted Lucid Gravity deliveries and overstating manufacturing capabilities. The lawsuit covers investors who purchased LCID stock between February 25, 2026 and April 13, 2026. The deadline to seek lead plaintiff appointment is July 28, 2026.

A securities class action lawsuit has been filed against Sportradar Group AG alleging the company made false statements about its compliance practices and knowingly worked with black-market gambling operators while claiming strict regulatory compliance. Investors who purchased SRAD securities between November 7, 2024 and April 21, 2026 have until July 17, 2026 to seek lead plaintiff status.

Futu Holdings Limited faces a federal securities class action lawsuit alleging the company made false statements about its regulatory compliance. The CSRC notified Futu on May 22, 2026 that certain entities conducted securities, public fund sales, and futures businesses in mainland China without required licenses, proposing penalties of approximately RMB1.85 billion (USD271 million). The stock fell over 27% on this disclosure. Investors who purchased Futu securities between May 24, 2023 and May 27, 2026 may be eligible to participate in the lawsuit, with an August 25, 2026 deadline to seek lead plaintiff status.

A securities class action lawsuit has been filed against Via Transportation alleging that IPO offering documents contained false and misleading statements regarding the company's Platform Annual Run-Rate Revenue and growth challenges in Germany. The stock has declined approximately 70% from its $46 IPO price in September 2025 to $14.52. Investors have until August 10, 2026 to seek lead plaintiff status.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Grail, Inc. (NASDAQ: GRAL) for allegedly making false and misleading statements about its NHS-Galleri cancer detection trial. The company touted confidence in the trial's success while concealing that the three-year trial period was insufficient to achieve its primary endpoint. On February 19, 2026, Grail announced the primary endpoint was not met, causing the stock to plummet 50.55% in a single day from $101.53 to $50.21 per share. Investors who purchased GRAL stock between May 13, 2025 and February 19, 2026 may be eligible to participate in the class action, with a deadline of August 4, 2026 to seek lead plaintiff appointment.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Calix, Inc. (NYSE: CALX) for allegedly making false and misleading statements about Q1 2026 margins. The company concealed that strong margins were artificially inflated by advanced memory component purchasing and failed to disclose dwindling supplies and upcoming negative margin pressure. When the truth emerged on April 21, 2026, CALX stock fell 13.98%, causing investor losses. The deadline to seek lead plaintiff appointment is July 27, 2026.